Gina Mazzariello
General Counsel at Amylyx Pharmaceuticals, Inc. (AMLX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 14SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 9,525190,849 held (−5%) | $32.46 | $309K | -13.3% |
| Sep 14SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 11190,838 held (−0%) | $33.34 | $367 | -15.6% |
| Jul 13SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell Plan | 15,000194,090 held (−7%) | $18.32 | $275K | +53.6% |
| Jul 13SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell Plan | 15,000179,090 held (−8%) | $17.61 | $264K | +59.8% |
| Mar 4SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 6,844134,430 held (−5%) | $14.52 | $99K | +93.8% |
| Feb 25SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 3,419141,274 held (−2%) | $14.14 | $48K | +99.0% |
| Feb 4SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 3,448144,693 held (−2%) | $14.65 | $51K | +92.1% |
| Oct 2SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 8,828148,141 held (−6%) | $14.58 | $129K | +93.0% |
- Sell
General Counsel Gina Mazzariello sold $275K of AMLX at $18.32 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Gina Mazzariello sold $264K of AMLX at $17.61 — pre-scheduled 10b5-1 plan sale.